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A girl was diagnosed with cystic fibrosis (CF) at birth, with repeatedly positive sweat tests and homozygous F508del
mutations of her CF transmembrane conductance regulator (CFTR) gene. From an early age, her lung disease was
more severe than her birth cohort peers despite aggressive treatment. At the age of 16 she was listed for lung
transplantation, but prior to transplant was not on systemic corticosteroids or other immunosuppressive agents.
In response to ex vivo stimulation, her pre-transplant peripheral blood T cells unexpectedly failed to produce
detectable levels of IFN-γ, unlike cells from healthy controls or from another girl with CF and lung disease of
comparable severity. Furthermore, naïve T cells freshly isolated from her peripheral blood showed a complete block
of T cell differentiation into Th1, Th17 and Treg lineages, even in the presence of cytokines known to promote
differentiation into the respective lineages. Her serology has been remarkably devoid of evidence of exposure to
viruses that have been associated with T cell exhaustion. However, her freshly isolated naïve T cells showed
sustained expression of markers of T cell exhaustion, which were further induced upon ex vivo stimulation, pointing
to T cell exhaustion as the cause of the failure of naïve T cells to undergo differentiation in response to cytokine
stimulation. Although excessive inflammation in CF lung can be both ineffective at clearing certain pathogens as
well as destructive to the lung tissue itself, adequate inflammation is a component of an effective overall immune
response to microbial pathogens. Our present findings suggest that intrinsic impairment of T cell differentiation
may have contributed to the greater severity and more rapid progression of her CF lung disease than of the lung
disease of most of her peers.
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Cystic fibrosis (CF), an autosomal recessive disease caused
by mutations in the CF transmembrane conductance
regulator (CFTR) gene [1], is an inherited, life-limiting
condition (reviewed in [2]). The main cause of death is CF
lung disease [3], with a vicious cycle of infection and
inflammation and interspersed acute exacerbations [2].
From early in life the typical CF patient, compared to
healthy controls, has evidence of sustained and severe
lung inflammation [4] and CF cells display a hyper-
inflammatory phenotype that is ineffective at clearing
bacterial pathogens but rather causes progressive tissue
damage [5]. T lymphocytes predominate in the CF airway* Correspondence: neil.sweezey@sickkids.ca
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stated.wall mucosa and submucosa, where the most severe tissue
damage is noted in patients with the most advanced
lung disease [6,7]. Studies have reported a skewing of
CF T cell immune responses toward the Th2 and more
recently Th17 lineages [8], with increased levels of pro-
inflammatory cytokines of the Th17 family implicated in
the destructive acute exacerbations [9]. In this context, we
were surprised to discover that one of our patients with
advanced CF lung disease, whilst on the list for lung trans-
plantation, demonstrated evidence of T cell exhaustion
with failure of naïve T cells to undergo differentiation into
cytokine producing effector cells in response to sti-
mulation. We speculate that an intrinsic, primary im-
pairment of T cell differentiation may have contributed to
the greater severity of her CF lung disease compared to
her peers.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Clinical history
Born at term in southern Ontario, Canada, of non-
consanguineous Caucasian parents following an unevent-
ful pregnancy, the patient was appropriate in size for a full
term baby and was discharged from hospital at four hours
of age. She was initially breast fed but readmitted to hos-
pital on the third day of life for failure to pass meconium.
Intestinal perforation was noted and about 15 cm of bowel
were resected. A diagnosis of CF was confirmed by repea-
ted sweat chloride tests, consistent with her CFTR ge-
notype of F508del homozygote. She has been followed
regularly at the multidisciplinary CF Clinic of The Hos-
pital for Sick Children, Toronto, on a quarterly basis at a
minimum. Maintaining adequate weight gain has been a
challenge. Although respiratory symptoms were not re-
cognized in the immediate newborn period, at three
months she had a severe pulmonary infection with Re-
spiratory Syncitial Virus. By the age of 9 months, her chest
X-Ray had early bronchiectatic changes that progressed to
diffuse cystic bronchiectasis at 12 years. Her respiratory
secretions intermittently grew Pseudomonas aeruginosa
since the age of two years, Staphylococcus aureus since
four years, as well as (less frequently) Haemophilus influ-
enzae and Stenotrophomonas maltophilia. Although As-
pergillus fumigatus has been identified several times, her
serum IgE levels and skin tests for aspergillus allergy have
been consistently normal, arguing against a diagnosis of
allergic bronchopulmonary aspergillosis. From an early
age, her pulmonary function has been more compromised
than that of her birth cohort peers at our institution.
Despite aggressive treatment of an increasingly frequent
series of acute pulmonary exacerbations, her FEV1 during
her 18th year was consistently below 30 and for several
months she required 3 - 4 L/min of supplemental oxygen
to maintain her hemoglobin oxygen saturations over 95%.
Until her lung transplantation just before her 18th birth-
day, she had not been on systemic corticosteroids or other
immunosuppressive agents. Her serology had been nega-
tive for IgG antibody to cytomegalovirus (CMV) by en-
zyme immunoassay (5 times out of 5 assessments over the
last 15 months) and also negative when assayed (on at
least one occasion) for IgG antibodies against each of
Epstein-Barr virus early or nuclear antigens, hepatitis C
virus, human immunodeficiency viruses 1 or 2, herpes
simplex virus, or Toxoplasma gondii. Her most recent ser-
ology was also negative for IgG antibody to Epstein-Barr
virus capsid antigen, although she had been positive for
this antibody once over a year ago. No evidence was found
for adenoviral DNA by polymerase chain reaction, or for
hepatitis B surface antigen or HIV P24 antigen by chemi-
luminescence immunoassay. No antigens of the following
respiratory viruses were detected on immunofluorescence
microscopy of respiratory secretions on nasopharyngealswabs: parainfluenza viruses 1, 2, 3, adenovirus, respira-
tory syncytial virus, human metapneumovirus, influenza
viruses A, B. Nevertheless, we have evidence of good anti-
body responses to her vaccines against measles, mumps,
rubella, varicella zoster virus and hepatitis B.
Immunological analysis of T cell response
We carried out immunological analysis of T cell re-
sponse in the peripheral blood of this patient prior to
her lung transplantation. Peripheral blood mononuclear
cells were isolated and stimulated with anti-CD3 and
anti-CD28 antibodies to assess for cytokine production
from T cells [10]. Whereas T cells amongst the mono-
nuclear cells from healthy controls produced identifiable
levels of IFN-γ which could be detected by flow cyto-
metry [11], T cells from the patient failed to show any
IFN-γ production (see Figure 1A). This could either be
explained by massive immunosuppression within the im-
mune system of the patient or an unlikely scenario in
which her T cells are intrinsically defective in cytokine
production. In order to test for this scenario, we isolated
and carried out differentiation of naïve CD4+ T cells into
inflammatory T helper type 1 (Th1) or T helper type 17
(Th17) lineages, or into regulatory T cells (Tregs), using
exogenous cytokines [12,13]. Although T cells from
healthy controls were able to differentiate into Th1 and
Th17 lineages, detected by production of IFN-γ and
Th17 respectively, along with differentiation into Tregs
detected by expression of the transcription actor Foxp3
[14], T cells from the patient showed a complete block
in T cell differentiation into the three T cell lineages
tested [12,13], pointing towards an intrinsic loss of T cell
responsiveness to differentiate in the presence of exoge-
nous cytokines (Figures 1B, C). Furthermore, this block in
T cell differentiation was not specific for one particular
lineage but was spread across all three lineages. Loss of re-
sponsiveness to exogenous cytokines led us to hypothesize
that the patient could be demonstrating T cell exhaustion.
Nature of T cell exhaustion
T cell exhaustion is a condition of progressive loss of T
cell function, which was initially reported as clonal dele-
tion of virus-specific T cells during high grade chronic
CMV infections [15,16]. Gradual improvements in me-
thodology for assessing T cell exhaustion identified that
there was no clonal deletion of T cells but rather the T
cells became unable to respond to stimuli due to sus-
tained expression of inhibitory receptors that prevent ef-
fector function of T cells [15,16]. In addition to CMV
infections, T cell exhaustion has also been reported fol-
lowing chronic exposure to HIV and/or Hepatitis C [17],
Hepatitis B [18], Plasmodium falciparum [19] and Toxo-
plasma gondii (reviewed in [20]), but we have no evi-
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Figure 1 CF patient A (the subject of this case report), but not CF patient B (another patient with CF lung disease of a similar degree
of severity) had reduced T cell responses compared with control. (A) IL-17 and IFN-γ production by T cells from mononuclear cells following
overnight stimulation. T cells from patient A produced deficient IL-17 and IFN-γ compared to control. (B) Naïve T cells were isolated from patients
A, B and a healthy control subject using magnetic sorting and differentiated into Th1 and Th17 lineages. Shown are representative flow cytometry
plots of production from differentiated Th1 and Th17 cells, respectively. Patient A, but not patient B, produced reduced levels of IFN-γ and IL-17
compared with control. (C) Naïve T cells were differentiated into regulatory T cells. Shown are representative flow cytometry plots of Foxp3 expression.
Patient A, but not patient B, produced reduced levels of Foxp3 compared with control. Representative of 2 - 3 independent experiments.
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knowledge, T cell exhaustion has not been documented
in CF.
Confirmation of T cell exhaustion
We hypothesized that the patient demonstrated T cell
exhaustion, whereby even naïve T cells were inept at
undergoing differentiation. In order to test this hypo-
thesis, we assessed the levels of T cell exhaustion mar-
kers, LAG-3 [21] and CTLA-4 [16], on unstimulated as
well as stimulated CD4+ T cells. Although LAG-3 and
CTLA-4 are not expressed on naïve T cells from healthy
individuals [22,23], freshly isolated naïve CD4+ T cells
from peripheral blood of our present patient showed sus-
tained expression of LAG-3 and CTLA-4, which werefurther induced even upon ex vivo stimulation with cyto-
kines that drive T cell proliferation (Figure 2). These find-
ings point towards T cell exhaustion as being the cause of
the failure of the patient’s T cells to undergo differen-
tiation in response to cytokine stimulation.
Does the T cell exhaustion represent a primary or
secondary immunodeficiency?
The patient’s respiratory secretions intermittently grew
P. aeruginosa, among other common bacterial pathogens
known for eliciting a vigorous immune response in CF.
Given the sustained and severe lung inflammation that
is typical of CF and given that chronic bacterial infections
are essentially universal in end-stage CF lung disease, if















Figure 2 Naïve T cells from Patient A, but not Patient B, showed marked induction of expression of the T cell exhaustion markers LAG-3
and CTLA-4 following stimulation with anti-CD3 and anti-CD28 antibodies. Representative plots of the expression of the T cell exhaustion
markers LAG-3 and CTLA-4 on unstimulated naïve T cells from patients A and B, and on T cells following stimulation with anti-CD3 and anti-CD28
antibodies. T cells from patient A, but not patient B, demonstrated a marked induction of the T cell exhaustion markers LAG-3 and CTLA-4.
Representative of 2 - 3 independent experiments.
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condary immunodeficiency would be commonly recog-
nized in CF, which is not at all the case. Moreover, the
subject of our present report had responses to measles,
mumps, rubella and varicella-zoster vaccinations that ap-
peared to be adequate, but remarkably little evidence of
chronic viral infections potentially associated with im-
munosuppression. Therefore we suggest that the T cell
exhaustion documented in our present patient likely rep-
resents a primary immunodeficiency, as a separate
medical issue in addition to CF, and not a secondary
outcome of ongoing CF pathology.
Previous reports of T cell anomalies in CF
Circulating T lymphocytes are known to have defects in
CFTR expression in CF [24]. Generally, reported abnor-
malities of T cells in CF have involved increased immune
responses, especially relating to Th17 helper T cells,
which have been linked to CF pulmonary exacerbations
[9,25] and to neutrophilia very early in life [26]. Elevated
sputum levels of Th17 cytokines are associated withactive CF lung infections with P. aeruginosa. Elevated
IL-17 levels predict future acquisition of P. aeruginosa in-
fections [8]. Again, to the best of our knowledge T cell ex-
haustion has not been documented in CF.
T cell exhaustion is not a universal occurrence in
end-stage CF lung disease
We proceeded to also study another teen-aged girl with
CF in our clinic, patient B, who had a very similar degree
of lung dysfunction (e.g., FEV1 chronically < 30% of the
predicted value) and who also underwent double lung
transplantation since the initial submission of this report.
Unlike the subject of our present report (patient A), whose
T cells demonstrated a marked induction of the T cell ex-
haustion markers LAG-3 and CTLA-4, pre-transplant pa-
tient B showed only a mild induction of LAG-3 and
CTLA-4 (Figure 2). Patient B also more closely resembled
control than patient A, in that patient B showed Th1 and
Th17 differentiation (Figures 1B, C), but compared to
control showed somewhat more Th17 and less Th1, con-
sistent with our recent report of an innate predisposition
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Th17 phenotype [27]. Thus we cannot suggest that the
T cell exhaustion described in patient A is an event that
occurs in all patients at this stage of CF lung disease. It re-
mains unknown if T cell exhaustion in CF is unique to pa-
tient A.
Conclusions
In CF, chronic lung disease is the main cause of morbid-
ity and mortality [3]. It is characterized by inflammation
that is early, sustained and severe [4]. Although excessive
inflammation in CF lung can be ineffective at clearing
certain pathogens as well as destructive to the lung tis-
sue itself [5], adequate inflammation is a component of
an effective overall immune response to microbial pa-
thogens. Our present findings suggest that intrinsic,
primary impairment of T cell differentiation may have
contributed to the overall greater severity and more
rapid progression of our patient’s CF lung disease than is
typical of the vast majority of her peers. An alternative ex-
planation, that we consider less likely, is that her T cell ex-
haustion may be the late result of the severity of her CF
lung disease. The prevalence and timing of T cell exhaus-
tion in the general CF population is unknown; however,
testing of another girl with end-stage CF lung disease did
not detect any evidence of T cell exhaustion. Clarification
of these issues may provide opportunities to design im-
proved immunomodulatory treatment for CF.
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